Copyright Reports & Markets. All rights reserved.

Global Bio-pharma Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Bio-pharma Market Overview

      • 1.1 Product Overview and Scope of Bio-pharma
      • 1.2 Bio-pharma Segment by Type
        • 1.2.1 Global Bio-pharma Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Recombinant Proteins
        • 1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
        • 1.2.5 Interferons
        • 1.2.6 Recombinant Human Insulin
        • 1.2.7 Erythropoietin
        • 1.2.8 Vaccines
        • 1.2.9 Growth Hormones
        • 1.2.10 Purified Proteins
        • 1.2.11 Others
      • 1.3 Bio-pharma Segment by Application
        • 1.3.1 Bio-pharma Consumption Comparison by Application (2014-2025)
        • 1.3.2 Metabolic Disorders
        • 1.3.3 Oncology
        • 1.3.4 Neurological Disorders
        • 1.3.5 Cardiovascular Diseases
        • 1.3.6 Inflammatory and Infectious Diseases
        • 1.3.7 Others
      • 1.3 Global Bio-pharma Market by Region
        • 1.3.1 Global Bio-pharma Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Bio-pharma Market Size
        • 1.4.1 Global Bio-pharma Revenue (2014-2025)
        • 1.4.2 Global Bio-pharma Production (2014-2025)

      2 Global Bio-pharma Market Competition by Manufacturers

      • 2.1 Global Bio-pharma Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Bio-pharma Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Bio-pharma Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Bio-pharma Production Sites, Area Served, Product Types
      • 2.5 Bio-pharma Market Competitive Situation and Trends
        • 2.5.1 Bio-pharma Market Concentration Rate
        • 2.5.2 Bio-pharma Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Bio-pharma Production Market Share by Regions

      • 3.1 Global Bio-pharma Production Market Share by Regions
      • 3.2 Global Bio-pharma Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Bio-pharma Production
        • 3.4.1 North America Bio-pharma Production Growth Rate (2014-2019)
        • 3.4.2 North America Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Bio-pharma Production
        • 3.5.1 Europe Bio-pharma Production Growth Rate (2014-2019)
        • 3.5.2 Europe Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Bio-pharma Production (2014-2019)
        • 3.6.1 China Bio-pharma Production Growth Rate (2014-2019)
        • 3.6.2 China Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Bio-pharma Production (2014-2019)
        • 3.7.1 Japan Bio-pharma Production Growth Rate (2014-2019)
        • 3.7.2 Japan Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Bio-pharma Consumption by Regions

      • 4.1 Global Bio-pharma Consumption by Regions
      • 4.2 North America Bio-pharma Consumption (2014-2019)
      • 4.3 Europe Bio-pharma Consumption (2014-2019)
      • 4.4 China Bio-pharma Consumption (2014-2019)
      • 4.5 Japan Bio-pharma Consumption (2014-2019)

      5 Global Bio-pharma Production, Revenue, Price Trend by Type

      • 5.1 Global Bio-pharma Production Market Share by Type (2014-2019)
      • 5.2 Global Bio-pharma Revenue Market Share by Type (2014-2019)
      • 5.3 Global Bio-pharma Price by Type (2014-2019)
      • 5.4 Global Bio-pharma Production Growth by Type (2014-2019)

      6 Global Bio-pharma Market Analysis by Applications

      • 6.1 Global Bio-pharma Consumption Market Share by Application (2014-2019)
      • 6.2 Global Bio-pharma Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Bio-pharma Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer Bio-pharma Production Sites and Area Served
        • 7.1.2 Bio-pharma Product Introduction, Application and Specification
        • 7.1.3 Pfizer Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 F. Hoffmann-La Roche AG
        • 7.2.1 F. Hoffmann-La Roche AG Bio-pharma Production Sites and Area Served
        • 7.2.2 Bio-pharma Product Introduction, Application and Specification
        • 7.2.3 F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Johnson & Johnson Services
        • 7.3.1 Johnson & Johnson Services Bio-pharma Production Sites and Area Served
        • 7.3.2 Bio-pharma Product Introduction, Application and Specification
        • 7.3.3 Johnson & Johnson Services Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sanofi, Amgen
        • 7.4.1 Sanofi, Amgen Bio-pharma Production Sites and Area Served
        • 7.4.2 Bio-pharma Product Introduction, Application and Specification
        • 7.4.3 Sanofi, Amgen Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 AbbVie
        • 7.5.1 AbbVie Bio-pharma Production Sites and Area Served
        • 7.5.2 Bio-pharma Product Introduction, Application and Specification
        • 7.5.3 AbbVie Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Merck & Co., Inc
        • 7.6.1 Merck & Co., Inc Bio-pharma Production Sites and Area Served
        • 7.6.2 Bio-pharma Product Introduction, Application and Specification
        • 7.6.3 Merck & Co., Inc Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Biogen Idec
        • 7.7.1 Biogen Idec Bio-pharma Production Sites and Area Served
        • 7.7.2 Bio-pharma Product Introduction, Application and Specification
        • 7.7.3 Biogen Idec Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Bayer AG
        • 7.8.1 Bayer AG Bio-pharma Production Sites and Area Served
        • 7.8.2 Bio-pharma Product Introduction, Application and Specification
        • 7.8.3 Bayer AG Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Eli Lilly and Company
        • 7.9.1 Eli Lilly and Company Bio-pharma Production Sites and Area Served
        • 7.9.2 Bio-pharma Product Introduction, Application and Specification
        • 7.9.3 Eli Lilly and Company Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis AG GlaxoSmithKline Plc
        • 7.10.1 Novartis AG GlaxoSmithKline Plc Bio-pharma Production Sites and Area Served
        • 7.10.2 Bio-pharma Product Introduction, Application and Specification
        • 7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Bristol-Myers Squibb Company
      • 7.12 AstraZeneca PLC
      • 7.13 Abbott Laboratories

      8 Bio-pharma Manufacturing Cost Analysis

      • 8.1 Bio-pharma Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Bio-pharma
      • 8.4 Bio-pharma Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Bio-pharma Distributors List
      • 9.3 Bio-pharma Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Bio-pharma Market Forecast

      • 11.1 Global Bio-pharma Production, Revenue Forecast
        • 11.1.1 Global Bio-pharma Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Bio-pharma Price and Trend Forecast (2019-2025)
      • 11.2 Global Bio-pharma Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Bio-pharma Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Bio-pharma Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Bio-pharma Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Bio-pharma Production, Revenue Forecast (2019-2025)
      • 11.3 Global Bio-pharma Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Bio-pharma Consumption Forecast (2019-2025)
        • 11.3.2 Europe Bio-pharma Consumption Forecast (2019-2025)
        • 11.3.3 China Bio-pharma Consumption Forecast (2019-2025)
        • 11.3.4 Japan Bio-pharma Consumption Forecast (2019-2025)
      • 11.4 Global Bio-pharma Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Bio-pharma Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Bio-pharma market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Bio-pharma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-pharma market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        F. Hoffmann-La Roche AG
        Johnson & Johnson Services
        Sanofi, Amgen
        AbbVie
        Merck & Co., Inc
        Biogen Idec
        Bayer AG
        Eli Lilly and Company
        Novartis AG GlaxoSmithKline Plc
        Bristol-Myers Squibb Company
        AstraZeneca PLC
        Abbott Laboratories

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Monoclonal Antibodies
        Recombinant Proteins
        Granulocyte-Colony Stimulating Factor (G-CSF)
        Interferons
        Recombinant Human Insulin
        Erythropoietin
        Vaccines
        Growth Hormones
        Purified Proteins
        Others

        Segment by Application
        Metabolic Disorders
        Oncology
        Neurological Disorders
        Cardiovascular Diseases
        Inflammatory and Infectious Diseases
        Others

        Buy now